Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy:: towards an adequate therapy

被引:109
|
作者
Marshall, MR
Ma, TM
Galler, D
Rankin, APN
Williams, AB
机构
[1] Middlemore Hosp, Dept Renal Med, Auckland 6, New Zealand
[2] Jinan Cent Hosp, Renal Ctr, Shandong, Peoples R China
[3] Middlemore Hosp, Dept Intens Care Med, Auckland 6, New Zealand
关键词
acute renal failure; continuous renal replacement therapy; intermittent haemodialysis; urea kinetic modelling; sustained low-efficiency dialysis;
D O I
10.1093/ndt/gfg625
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Sustained low-efficiency daily dialysis (SLEDD) is an increasingly popular renal replacement therapy for intensive care unit (ICU) patients. SLEDD has been previously reported to provide good solute control and haemodynamic stability. However, continuous renal replacement therapy (CRRT) is considered superior by many ICU practitioners, due first to the large amounts of convective clearance achieved and second to the ability to deliver treatment independently of nephrology services. We report on a program of sustained low-efficiency daily diafiltration (SLEDD-f) delivered autonomously by ICU nursing personnel, and benchmark solute clearance data with recently published reports that have provided dose-outcome relationships for renal replacement therapy in this population. Methods. SLEDD-f treatments were delivered using countercurrent dialysate flow at 200 ml/min and online haemofiltration at 100 ml/min for 8 h on a daily or at least alternate day basis. All aspects of SLEDD-f were managed by ICU nursing personnel. Clinical parameters, patient outcomes and solute levels were monitored. Kt/V, corrected equivalent renal urea clearance (EKRc) and theoretical Kt/VB12 were calculated. Results. Fifty-six SLEDD-f treatments in 24 critically ill acute renal failure patients were studied. There were no episodes of intradialytic hypotension or other complications. Observed hospital mortality was 46%, not significantly different from the expected mortality as determined from the APACHE II illness severity scoring system. Electrolyte control was excellent. Kt/V per completed treatment was 1.43 +/- 0.28 (0.96-2.0). Kt/VB12 per completed treatment was 1.02 +/- 0.21 (0.6-1.38). EKRc for patients was 35.7 +/- 6.4 ml/min (25.0-48.2). Conclusion. SLEDD-f provides stable renal replacement therapy and good clinical outcomes. Logistic elements. of SLEDD-f delivery by ICU nursing personnel are satisfactory. Small solute clearance is adequate by available standards for CRRT and intermittent haemodialysis, and larger solute clearance considerable. SLEDD-f is a viable alternative to CRRT in this setting.
引用
收藏
页码:877 / 884
页数:8
相关论文
共 50 条
  • [31] Prognostic factors in critically ill surgical patients requiring continuous renal replacement therapy
    Fertmann, Jan
    Wolf, Hilde
    Kuechenhoff, Helmut
    Hofner, Benjamin
    Jauch, Karl-Walter
    Hartl, Wolfgang H.
    JOURNAL OF NEPHROLOGY, 2008, 21 (06) : 909 - 918
  • [32] Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis
    Rider, Taylor R.
    Silinskie, Kevin M.
    Hite, Mindee S.
    Bress, Jonathan
    PHARMACOTHERAPY, 2020, 40 (10): : 1036 - 1041
  • [33] Prognosis in critically ill children requiring continuous renal replacement therapy
    Carmen Fernández
    Jesús López-Herce
    Jose C. Flores
    Dolores Galaviz
    Marta Rupérez
    Kay B. Brandstrup
    Amaya Bustinza
    Pediatric Nephrology, 2005, 20 : 1473 - 1477
  • [34] Outcomes of critically ill children requiring continuous renal replacement therapy
    Hayes, Leslie W.
    Oster, Robert A.
    Tofil, Nancy M.
    Tolwani, Ashita J.
    JOURNAL OF CRITICAL CARE, 2009, 24 (03) : 394 - 400
  • [35] Prognosis in critically ill children requiring continuous renal replacement therapy
    Fernández, C
    López-Herce, J
    Flores, JC
    Galaviz, D
    Rupérez, M
    Brandstrup, KB
    Bustinza, A
    PEDIATRIC NEPHROLOGY, 2005, 20 (10) : 1473 - 1477
  • [36] Preemptive renal replacement therapy in critically ill patients?
    Meersch, Melanie
    Zarbock, Alexander
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (16)
  • [37] Continuous renal replacement therapy in critically ill patients
    Ronco, C
    Bellomo, R
    Ricci, Z
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 67 - 72
  • [38] Outcomes in Critically Ill COVID-19 Patients with AKI Requiring Renal Replacement Therapy
    Douen, Aaron
    McGraw, Gregory M.
    Xiong, Bei
    Banan, Rohan
    Samuel, Joshua
    Frolova, Elena
    El-Hennawy, Adel S.
    Lee, Winston
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 775 - 775
  • [39] Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED)
    Deshpande, Priya
    Chen, Julie
    Gofran, Anita
    Murea, Marianna
    Golestaneh, Ladan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (08) : 2632 - 2636
  • [40] Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy
    Hames, Daniel L.
    Ferguson, Michael A.
    Salvin, Joshua W.
    PEDIATRIC CRITICAL CARE MEDICINE, 2019, 20 (11) : 1069 - 1077